IC
CASI

Ikarian Capital’s CASI Pharmaceuticals CASI Stock Holding History

Ikarian Capital’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-132,014
Closed -$378K – 119
2022
Q2 		$378K Sell
132,014
-2
-0% -$9 0.07% 107
2022
Q1 		$1.07M Buy
132,016
+9,709
+8% +$76.3K 0.14% 97
2021
Q4 		$978K Hold
122,307
– – 0.15% 101
2021
Q3 		$1.46M Sell
122,307
-4,508
-4% -$61K 0.1% 141
2021
Q2 		$1.97M Hold
126,815
– – 0.16% 129
2021
Q1 		$3.04M Hold
126,815
– – 0.1% 171
2020
Q4 		$3.74M Sell
126,815
-27,176
-18% -$591K 0.16% 113
2020
Q3 		$2.36M Buy
153,991
+50,000
+48% +$942K 0.17% 106
2020
Q2 		$2.6M Hold
103,991
– – 0.21% 96
2020
Q1 		$2.12M Buy
+103,991
New +$2.48M 0.16% 94

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return